Ani Pharmaceuticals (ANIP) Interest Expenses (2010 - 2013)

Ani Pharmaceuticals has disclosed Interest Expenses across 4 years of filings, most recently posting $98.0 for Q4 2013.

• In Q4 2013, Interest Expenses fell 99.89% year-over-year to $98.0; the TTM figure through Mar 2014 stood at $374574.0 (down 50.91% YoY), while the FY2013 annual figure was $467000.0, down 64.81% from the prior year.
• Interest Expenses came in at $98.0 for Q4 2013 at Ani Pharmaceuticals, down from $374476.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $501002.0 in Q2 2012 to a low of $98.0 in Q4 2013.
• Average Interest Expenses over 4 years is $175679.7, with a median of $172000.0 recorded in 2010.
• Year-over-year, Interest Expenses jumped 191.28% in 2012 and sank 99.89% in 2013.
• Over 4 years, Interest Expenses stood at $172000.0 in 2010, then dropped by 3.74% to $165573.0 in 2011, then slumped by 46.93% to $87863.0 in 2012, then slumped by 99.89% to $98.0 in 2013.
• Per Business Quant data, the three most recent Interest Expenses figures were $98.0 in Q4 2013, $374476.0 in Q2 2013, and $93000.0 in Q1 2013.